Post-transplant cyclophosphamide, abatacept, and vedolizumab to prevent GVHD after hematopoietic stem cells transplantation in children with acute leukemia: results of a prospective trial

Bone Marrow Transplant. 2025 Apr 25. doi: 10.1038/s41409-025-02566-6. Online ahead of print.

Authors

Affiliations

¹ Dmitry Rogachev National Medical Research Center Of Pediatric Hematology, Oncology and Immunology, Moscow, Russia.
² Dmitry Rogachev National Medical Research Center Of Pediatric Hematology, Oncology and Immunology, Moscow, Russia. mmaschan@yandex.ru.

PMID: 40281208
DOI: 10.1038/s41409-025-02566-6

No abstract available

Publication types

Letter